Asbestosis Treatment: What Patients and Families Need to Know
A diagnosis of asbestosis or mesothelioma is devastating — and the first question most patients and families ask is whether anything can be done. The honest answer is that there is currently no cure for either condition, but asbestosis treatment has advanced considerably, and patients today have access to therapies, rehabilitation programmes, and supportive care that can meaningfully improve quality of life and, in some cases, extend survival.
Understanding what is available — and why these conditions are so clinically challenging — helps patients advocate effectively within the NHS and make informed decisions about their care.
Why Asbestos-Related Illnesses Are So Hard to Treat
When asbestos fibres are inhaled, they become permanently embedded in lung tissue. The body cannot break them down or expel them. Over time — often decades after the original exposure — they trigger irreversible scarring, chronic inflammation, and in some cases, malignant change.
By the time symptoms appear, significant damage has usually already occurred. This latency period, which can span 20 to 40 years, is precisely what makes asbestos diseases so clinically difficult to manage. Treatment cannot undo fibrosis or reverse tumour development, but it can slow progression, control symptoms, and in some situations extend survival meaningfully.
The conditions most commonly linked to asbestos exposure are:
- Asbestosis — a chronic, progressive lung disease caused by fibrosis (scarring) of lung tissue resulting from prolonged asbestos inhalation
- Mesothelioma — a rare and aggressive cancer affecting the lining of the lungs (pleura), abdomen (peritoneum), or heart (pericardium)
- Pleural plaques and pleural thickening — non-malignant changes to the pleural lining that can affect breathing
- Asbestos-related lung cancer — distinct from mesothelioma, but similarly linked to asbestos exposure, particularly in those who also smoked
Each condition requires a different clinical approach. This article focuses primarily on asbestosis treatment and mesothelioma management, as these represent the most serious outcomes of asbestos exposure.
Asbestosis Treatment: Managing a Progressive Condition
There is no treatment that reverses the scarring already present in the lungs of someone with asbestosis. The entire focus of clinical management is on preserving lung function for as long as possible, reducing breathlessness, preventing complications, and maintaining quality of life.
Pulmonary Rehabilitation
Pulmonary rehabilitation is one of the most effective and evidence-based interventions available to asbestosis patients, and it is routinely offered through NHS respiratory services. It is a structured programme combining supervised exercise, breathing technique education, nutritional support, and psychological care — all tailored to the individual’s current lung capacity.
The aim is not to push through breathlessness but to retrain the body to use oxygen more efficiently, reduce the sensation of breathlessness during everyday activity, and build endurance gradually over time. Patients who complete pulmonary rehabilitation consistently report improvements in their ability to carry out daily tasks and a reduction in anxiety around breathing difficulties.
Many patients also experience fewer hospital admissions following the programme — a significant benefit both for the individual and for NHS resources.
Oxygen Therapy
When asbestosis progresses to the point where blood oxygen levels drop to unsafe levels, supplemental oxygen therapy becomes necessary. This can be administered via nasal cannulas, face masks, or home oxygen concentrators, depending on whether the patient requires continuous or ambulatory oxygen.
Home oxygen therapy allows patients to continue normal daily routines while receiving the respiratory support they need. Prescription is based on pulmonary function tests and blood gas analysis, and flow rates are reviewed regularly as the condition progresses.
It is worth being clear: oxygen therapy does not slow the underlying disease. It manages the symptomatic consequences of reduced lung function — but it does so effectively and can make a substantial difference to daily life.
Medication for Asbestosis
While no medication reverses asbestosis, several drugs are used to manage symptoms and reduce the risk of complications:
- Bronchodilators — inhaled medications that relax and widen the airways, reducing breathlessness and wheeze
- Corticosteroids — inhaled or oral steroids to reduce airway inflammation
- Mucolytics — help thin and clear excess mucus from the airways
- Antifibrotic drugs — medications such as pirfenidone and nintedanib, developed primarily for idiopathic pulmonary fibrosis, may be considered in some cases of asbestosis-related fibrosis, depending on clinical assessment
- Antibiotics — patients with reduced lung function are more vulnerable to respiratory infections, particularly pneumonia, and often require prompt antibiotic treatment
- Pain relief — may be required for chest discomfort, particularly in more advanced stages
Annual influenza vaccination and pneumococcal vaccination are also strongly recommended to reduce the risk of serious respiratory infections in this patient group.
Stopping Further Damage
Any further asbestos exposure must be eliminated entirely — this is a non-negotiable element of asbestosis management. Patients who smoke should be supported to stop immediately, as smoking and asbestos exposure together dramatically increase the risk of developing lung cancer on top of existing asbestosis.
This is also why asbestos management in buildings matters so much. If you are responsible for a property and are unsure whether asbestos-containing materials are present, arranging asbestos testing is a straightforward first step to understanding the risk.
Mesothelioma Treatment: A Multi-Modal Approach
Mesothelioma is an aggressive cancer, and treatment decisions depend heavily on the stage at diagnosis, the patient’s overall health and fitness, and the specific type of mesothelioma — pleural mesothelioma being the most common in the UK. For most patients, treatment aims to slow progression, manage symptoms, and extend survival rather than to cure.
For a smaller group — typically those diagnosed at an earlier stage with good performance status — more aggressive treatment with intent to extend survival may be considered as part of a specialist multidisciplinary plan.
Chemotherapy
Chemotherapy remains the most widely used systemic treatment for pleural mesothelioma. The standard first-line regimen combines pemetrexed and cisplatin (or carboplatin where cisplatin is not tolerated), administered intravenously in cycles over several months.
This combination works by disrupting the ability of cancer cells to divide and replicate. It will not eliminate the cancer for most patients, but it can shrink tumours, slow growth, and meaningfully extend survival compared to no treatment. Side effects — including fatigue, nausea, and increased susceptibility to infection — are carefully managed by the oncology team, with blood counts monitored regularly and dose adjustments made where necessary.
Immunotherapy
Immunotherapy has become an increasingly important treatment option for mesothelioma. The dual checkpoint inhibitor regimen of nivolumab combined with ipilimumab has shown improved survival outcomes compared to chemotherapy alone in some patient groups, and is now available through NHS England for eligible patients.
Immunotherapy works by releasing the brakes on the body’s own immune system, enabling it to recognise and attack cancer cells more effectively. It is not suitable for everyone and can cause immune-related side effects, but it represents a genuine and significant step forward in the treatment of this disease.
Radiotherapy
Radiotherapy uses high-energy radiation to target and destroy cancer cells. In mesothelioma, it is most commonly used in specific clinical situations:
- To prevent tumour seeding along biopsy or drain sites (prophylactic irradiation)
- As palliative treatment to relieve pain or manage localised tumour growth
- As part of a multimodal treatment plan alongside surgery and chemotherapy in eligible patients
Modern radiotherapy techniques, including intensity-modulated radiotherapy (IMRT), allow for more precise targeting of tumours, reducing radiation exposure to surrounding healthy tissue and improving tolerability for patients.
Surgery
Surgical intervention is considered for a minority of mesothelioma patients — those diagnosed early enough and physically fit enough to withstand major thoracic surgery. The two main procedures are:
- Pleurectomy/decortication (P/D) — removal of the pleural lining and visible tumour tissue, while preserving the lung
- Extrapleural pneumonectomy (EPP) — removal of the entire affected lung along with the pleura, part of the diaphragm, and the pericardium
Surgery is almost always used as part of a multimodal approach — combined with chemotherapy and/or radiotherapy — rather than as a standalone treatment. The decision to operate is made by a specialist multidisciplinary team following detailed assessment of risk versus potential benefit for each individual patient.
Palliative and Supportive Care
For many patients with mesothelioma, particularly those diagnosed at a later stage or who are not fit enough for aggressive treatment, palliative care forms the backbone of their management. This is not giving up — it is expert medical care focused on symptom control, comfort, and quality of life.
Key elements of palliative care for mesothelioma include:
- Pleural drainage procedures to remove fluid build-up (pleural effusion) that causes breathlessness
- Pain management, often involving specialist palliative medicine teams
- Psychological support for patients and families
- Nutritional support
- Access to hospice services when appropriate
Clinical Trials and Emerging Treatments
Research into asbestosis treatment and mesothelioma therapies is ongoing, and clinical trials offer some patients access to therapies not yet available through standard NHS pathways. This is an area where the picture is changing, and patients should ask their specialist team about currently recruiting trials.
Areas of active research include:
- Targeted therapies — drugs designed to interfere with specific molecular pathways involved in mesothelioma cell growth
- CAR-T cell therapy — a form of immunotherapy involving genetically modified immune cells engineered to target mesothelioma cells
- Photodynamic therapy — using light-activated drugs to destroy cancer cells, currently under investigation in combination with surgery
- Antifibrotic therapies — exploring whether drugs approved for idiopathic pulmonary fibrosis can slow asbestosis progression more broadly
Patients interested in clinical trial participation should speak to their NHS specialist team or visit the NIHR Clinical Research Network website for information on currently recruiting studies.
The Importance of Early Detection
The earlier an asbestos-related illness is detected, the more treatment options are available and the better the likely outcome. This is particularly true for mesothelioma, where early-stage diagnosis opens the door to surgical intervention and more aggressive treatment strategies.
Anyone with a history of asbestos exposure — whether occupational or through living or working in a building containing asbestos — should inform their GP and seek monitoring if they develop any respiratory symptoms, however mild. Persistent cough, breathlessness on exertion, and chest tightness should never be dismissed in someone with a known exposure history.
Symptoms often appear decades after exposure, so even historical contact with asbestos — in a school, office, factory, or home built before 2000 — is clinically relevant and worth disclosing.
What This Means for Building Owners and Duty Holders
The medical reality of asbestosis and mesothelioma makes one thing absolutely clear: prevention is the only truly effective intervention. There is no reversing the damage once fibres are inhaled. Once a person develops asbestosis, the best available asbestosis treatment can only manage — not cure — the disease.
Under the Control of Asbestos Regulations, duty holders — including property managers, landlords, and employers — have a legal obligation to identify, assess, and manage asbestos-containing materials in non-domestic premises. This includes maintaining an up-to-date asbestos register and arranging a re-inspection survey at regular intervals to ensure the condition of known asbestos has not deteriorated.
Failure to manage asbestos responsibly puts occupants, workers, and visitors at risk of developing conditions that, decades later, may have no curative treatment available.
If you are unsure whether asbestos is present in your property, a professional survey is the starting point. For smaller or more targeted investigations, you can also use an asbestos testing kit to collect samples for laboratory analysis — though a full survey remains the most thorough approach for duty holders managing larger or more complex premises.
Supernova Asbestos Surveys provides UKAS-accredited asbestos surveys, asbestos testing, re-inspection surveys, and removal across the UK. Our surveyors work with commercial property managers, landlords, schools, housing associations, and industrial operators to help them meet their legal duties and protect the people who use their buildings.
We cover the whole of the UK, including asbestos survey London, asbestos survey Manchester, and asbestos survey Birmingham, with clear, actionable survey reports that help you manage asbestos responsibly and demonstrate compliance.
Call us on 020 4586 0680 or visit asbestos-surveys.org.uk to arrange a survey, book a re-inspection, or request a testing kit.
Frequently Asked Questions
Is there a cure for asbestosis?
No. Asbestosis causes permanent scarring of the lungs, and there is currently no treatment that reverses this damage. Asbestosis treatment focuses on managing symptoms, preserving lung function, and maintaining quality of life through pulmonary rehabilitation, oxygen therapy, and medication. Early diagnosis allows more options to be used effectively.
What is the most effective treatment for mesothelioma?
Treatment for mesothelioma depends on the stage at diagnosis and the patient’s overall health. For many patients, chemotherapy using pemetrexed and cisplatin remains the standard first-line approach. Immunotherapy — particularly the combination of nivolumab and ipilimumab — is now available through NHS England for eligible patients and has shown improved survival outcomes in some groups. A small number of patients may be suitable for surgery as part of a multimodal treatment plan.
How long after asbestos exposure do symptoms appear?
Asbestos-related diseases have a long latency period. Symptoms of asbestosis typically appear 20 to 30 years after initial exposure, while mesothelioma can take 30 to 40 years or more to develop. This is why people with a history of asbestos exposure should inform their GP and seek medical attention promptly if any respiratory symptoms develop, even if the exposure occurred many years ago.
Can asbestosis get worse over time?
Yes. Asbestosis is a progressive condition, meaning the scarring in the lungs tends to worsen over time even after exposure has ended. The rate of progression varies between individuals. Stopping any further asbestos exposure, avoiding smoking, maintaining vaccinations, and engaging with pulmonary rehabilitation can all help slow the functional decline associated with the disease.
What should I do if I think my building contains asbestos?
If you are a duty holder responsible for a non-domestic property built before 2000, you should arrange a professional asbestos survey to identify and assess any asbestos-containing materials. Under the Control of Asbestos Regulations, you have a legal obligation to manage asbestos in your premises. Supernova Asbestos Surveys can arrange a survey, re-inspection, or testing service — call 020 4586 0680 or visit asbestos-surveys.org.uk.